Portal de Periódicos da CAPES

Artigo Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

SARS‐CoV‐2 and myasthenia

2021; Wiley; Volume: 93; Issue: 7 Linguagem: Inglês

10.1002/jmv.26501

1096-9071

Josef Finsterer, Fúlvio A. Scorza, Carla A. Scorza, Ana C. Fiorini,

Peripheral Neuropathies and Disorders

Journal of Medical VirologyVolume 93, Issue 7 p. 4133-4135 LETTER TO THE EDITOR SARS-CoV-2 and myasthenia Josef Finsterer MD, PhD, Corresponding Author Josef Finsterer MD, PhD [email protected] orcid.org/0000-0003-2839-7305 Klinik Landstrasse, Messerli Institute, Vienna, Austria Correspondence Josef Finsterer, MD, PhD, Postfach 20, 1180 Vienna Austria. Email: [email protected]Search for more papers by this authorFulvio A. Scorza MD, Fulvio A. Scorza MD Disciplina de Neurociência, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, BrasilSearch for more papers by this authorCarla A. Scorza MD, Carla A. Scorza MD Disciplina de Neurociência, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, BrasilSearch for more papers by this authorAna C. Fiorini MD, Ana C. Fiorini MD Departamento de Fonoaudiologia, Programa de Estudos Pós-Graduado em Fonoaudiologia, Pontifícia Universidade Católica de São Paulo (PUC-SP), Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, BrazilSearch for more papers by this author Josef Finsterer MD, PhD, Corresponding Author Josef Finsterer MD, PhD [email protected] orcid.org/0000-0003-2839-7305 Klinik Landstrasse, Messerli Institute, Vienna, Austria Correspondence Josef Finsterer, MD, PhD, Postfach 20, 1180 Vienna Austria. Email: [email protected]Search for more papers by this authorFulvio A. Scorza MD, Fulvio A. Scorza MD Disciplina de Neurociência, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, BrasilSearch for more papers by this authorCarla A. Scorza MD, Carla A. Scorza MD Disciplina de Neurociência, Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM), São Paulo, BrasilSearch for more papers by this authorAna C. Fiorini MD, Ana C. Fiorini MD Departamento de Fonoaudiologia, Programa de Estudos Pós-Graduado em Fonoaudiologia, Pontifícia Universidade Católica de São Paulo (PUC-SP), Escola Paulista de Medicina/Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, BrazilSearch for more papers by this author First published: 10 September 2020 https://doi.org/10.1002/jmv.26501Citations: 2Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Nyasulu J, Pandya H. The effects of coronavirus disease 2019 pandemic on the South African health system: a call to maintain essential health services. Afr J Prim Health Care Fam Med. 2020; 12(1): e1-e5. https://doi.org/10.4102/phcfm.v12i1.2480 10.4102/phcfm.v12i1.2480 PubMedWeb of Science®Google Scholar 2Wei J, Zhao J, Han M, Meng F, Zhou J. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity. J Immunother Cancer. 2020; 8(2):e000862. https://doi.org/10.1136/jitc-2020-000862 10.1136/jitc-2020-000862 PubMedWeb of Science®Google Scholar 3Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia gravis associated With SARS-CoV-2 infection. Ann Intern Med. 2020; 10: 7326/L20-0845. https://doi.org/10.7326/L20-0845 Google Scholar 4Scoppetta C, Casciato S, Di, Gennaro G. Speculative clues on myasthenia gravis and COVID-19. Eur Rev Med Pharmacol Sci. 2020; 24(15): 7925-7926. https://doi.org/10.26355/eurrev_202008_22474 CASPubMedWeb of Science®Google Scholar 5Delly F, Syed MJ, Lisak RP, Zutshi D. Myasthenic crisis in COVID-19. J Neurol Sci. 2020; 414:116888. https://doi.org/10.1016/j.jns.2020.116888 10.1016/j.jns.2020.116888 CASPubMedWeb of Science®Google Scholar 6Hübers A, Lascano AM, Lalive PH. Management of patients with generalised myasthenia gravis and COVID-19: four case reports [published online ahead of print July 10, 2020]. J Neurol Neurosurg Psychiatry. 2020. 10.1136/jnnp-2020-323565 PubMedWeb of Science®Google Scholar 7Rein N, Haham N, Orenbuch-Harroch E, et al. Description of 3 patients with myasthenia gravis and COVID-19. J Neurol Sci. 2020; 417:117053. https://doi.org/10.1016/j.jns.2020.117053 10.1016/j.jns.2020.117053 CASPubMedWeb of Science®Google Scholar 8Ramaswamy SB, Govindarajan R. COVID-19 in refractory myasthenia gravis: a case report of successful outcome. J Neuromuscul Dis. 2020; 7(3): 361-364. https://doi.org/10.3233/JND-200520 10.3233/JND-200520 PubMedGoogle Scholar 9Salik I, Rodhouse HB, Barst S. Myasthenic crisis in the setting of coronavirus disease 2019 (COVID-19). J Clin Anesth. 2020; 67:110001. https://doi.org/10.1016/j.jclinane.2020.110001 10.1016/j.jclinane.2020.110001 CASPubMedWeb of Science®Google Scholar 10Anand P, Slama MCC, Kaku M, et al. COVID-19 in patients with myasthenia gravis. Muscle Nerve. 2020; 62(2): 254-258. https://doi.org/10.1002/mus.26918 10.1002/mus.26918 CASPubMedWeb of Science®Google Scholar 11Finsterer J, Scorza FA, Scorza CA. Diagnosing myasthenic crisis in SARS-CoV-2 infected patients requires adherence to appropriate criteria. J Neurol Sci. 2020:117062. https://doi.org/10.1016/j.jns.2020.117062 10.1016/j.jns.2020.117062 PubMedWeb of Science®Google Scholar 12Solé G, Salort-Campana E, Pereon Y, et al. Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. Rev Neurol. 2020; 176(6): 507-515. https://doi.org/10.1016/j.neurol.2020.04.004 10.1016/j.neurol.2020.04.004 CASPubMedWeb of Science®Google Scholar 13Pradhan S, Pardasani V, Ramteke K. Azithromycin-induced myasthenic crisis: reversibility with calcium gluconate. Neurol India. 2009; 57(3): 352-353. https://doi.org/10.4103/0028-3886.53270 10.4103/0028-3886.53270 PubMedWeb of Science®Google Scholar 14Saldarriaga Rivera LM, Fernández Ávila D, Molano WB, et al. Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology. (Recomendaciones sobre el manejo de pacientes adultos con enfermedades reumáticas en el contexto de la infección por SARS-CoV-2/COVID-19. Asociación Colombiana de Reumatología). Revista Colombiana de Reumatología. 2020; 27(3): 230-241. https://doi.org/10.1016/j.reuma.2020.06.011 10.1016/j.rcreu.2020.05.007 Google Scholar 15Wang AX, Quintero Cardona O, Ho DY, Busque S, Lenihan CR. Influence of immunosuppression on seroconversion against SARS-CoV-2 in two kidney transplant recipients. Transpl Infect Dis. 2020:e13423. https://doi.org/10.1111/tid.13423 PubMedWeb of Science®Google Scholar 16Kushlaf H. COVID-19 in muscle-specific kinase myasthenia gravis: a case report [published online ahead of print July 13, 2020]. Muscle Nerve. 2020. https://doi.org/10.1002/mus.27020 10.1002/mus.27020 Web of Science®Google Scholar Citing Literature Volume93, Issue7Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐XIIIJuly 2021Pages 4133-4135 ReferencesRelatedInformation